HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ureteroscopic approach to upper-tract urothelial tumors.

Abstract
Transitional-cell carcinoma (TCC) of the upper urinary tract has traditionally been managed by nephroureterectomy, whereas nephron-sparing surgery has been reserved for those few patients with solitary kidneys or bilateral lesions. However, with the introduction of improved diagnostic and therapeutic technology, including smaller ureteroscopes and working instruments, and the concomitant ease of surveillance, ureteroscopic treatment of upper-tract urothelial tumors has become a reasonable alternative to open operative intervention in patients requiring conservative management. Furthermore, as preoperative grading and staging have improved, ureteroscopic treatment of upper-tract urothelial tumors is assuming an increasingly important role in the management of some patients who might have otherwise been treated with a nephroureterectomy. The technique of ureteroscopic resection is described in detail.
AuthorsS J Savage, S B Streem
JournalJournal of endourology (J Endourol) Vol. 14 Issue 3 Pg. 275-8; discussion 278-9 (Apr 2000) ISSN: 0892-7790 [Print] United States
PMID10795618 (Publication Type: Journal Article)
Topics
  • Carcinoma, Transitional Cell (complications, pathology, surgery)
  • Humans
  • Laser Therapy
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Treatment Outcome
  • Ureteral Neoplasms (complications, pathology, surgery)
  • Ureteral Obstruction (etiology, pathology, surgery)
  • Ureteroscopy
  • Urothelium (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: